Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of February 2019. The registrant, a German partnership limited by shares, filed this report to distribute a press release issued on February 20, 2019 (Exhibit 99.1). The document serves as a formal notification to the SEC regarding this external communication.
Key Financial Metrics
The provided filing text contains only the cover page and signature block of the Form 6-K. It does not include the content of the referenced press release or any financial data tables. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as the specific content of the February 20, 2019 press release is not included in the input.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements would be located within the attached press release (Exhibit 99.1), which is not part of the provided text.
Investor Verification Checklist
- Verify the full content of the Press Release issued on February 20, 2019 (Exhibit 99.1) to obtain actual financial figures and strategic updates.
- Confirm whether the press release contains updated guidance or significant operational changes not reflected in prior annual reports.
- Review the signatures of CEO Rice Powell and CFO Michael Brosnan to confirm authorization of the disclosure.